Clinical Trial: Multi-center, Randomized, Double-blind, Placebo Controlled, Parallel Clinical Trial for the Evauation of the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07016269) titled 'Multi-center, Randomized, Double-blind, Placebo Controlled, Parallel Clinical Trial for the Evauation of the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia' on May 29.

Brief Summary: The objective of this clinical trial is to evaluate the efficacy and safety of CnU capsule 500 mg administration in patients with biliary dyspepsia

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Biliary Dyspepsia

Intervention: DRUG: CnU capsule 500 mg(250mg 2 capsule)

According to the randomly assigned treatment groups, the medication will be administered orally at a dose of 500 mg (2 capsules) once ...